These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

549 related items for PubMed ID: 6832061

  • 1. Dopamine receptors on intact anterior pituitary cells in culture: functional association with the inhibition of prolactin and thyrotropin.
    Foord SM, Peters JR, Dieguez C, Scanlon MF, Hall R.
    Endocrinology; 1983 May; 112(5):1567-77. PubMed ID: 6832061
    [Abstract] [Full Text] [Related]

  • 2. Hypothyroid pituitary cells in culture: an analysis of thyrotropin and prolactin responses to dopamine (DA) and DA receptor binding.
    Foord SM, Peters JR, Dieguez C, Jasani B, Hall R, Scanlon MF.
    Endocrinology; 1984 Jul; 115(1):407-15. PubMed ID: 6428863
    [Abstract] [Full Text] [Related]

  • 3. Thyrotropin regulates thyrotroph responsiveness to dopamine in vitro.
    Foord SM, Peters JR, Dieguez C, Shewring G, Hall R, Scanlon MF.
    Endocrinology; 1986 Apr; 118(4):1319-26. PubMed ID: 3004910
    [Abstract] [Full Text] [Related]

  • 4. Alpha 1-adrenoreceptors on intact rat anterior pituitary cells: correlation with adrenergic stimulation of thyrotropin secretion.
    Peters JR, Foord SM, Dieguez C, Scanlon MF, Hall R.
    Endocrinology; 1983 Jul; 113(1):133-40. PubMed ID: 6305631
    [Abstract] [Full Text] [Related]

  • 5. Alpha 1-adrenoreceptors and alpha 1-adrenoreceptor-mediated thyrotropin release in cultures of euthyroid and hypothyroid rat anterior pituitary cells.
    Dieguez C, Foord SM, Peters JR, Hall R, Scanlon MF.
    Endocrinology; 1985 Aug; 117(2):624-30. PubMed ID: 2990855
    [Abstract] [Full Text] [Related]

  • 6. Pharmacologic evidence that a D2 receptor subtype mediates dopaminergic stimulation of prolactin secretion from the anterior pituitary gland.
    Burris TP, Stringer LC, Freeman ME.
    Neuroendocrinology; 1991 Aug; 54(2):175-83. PubMed ID: 1685014
    [Abstract] [Full Text] [Related]

  • 7. Antipsychotic drugs inhibit prolactin release from rat anterior pituitary cells in culture by a mechanism not involving the dopamine receptor.
    West B, Dannies PS.
    Endocrinology; 1979 Apr; 104(4):877-80. PubMed ID: 436760
    [Abstract] [Full Text] [Related]

  • 8. Absence of high affinity dopamine receptor in GH3 cells: a prolactin-secreting clone resistant to the inhibitory action of dopamine.
    Cronin MJ, Faure N, Martial JA, Weiner RI.
    Endocrinology; 1980 Mar; 106(3):718-23. PubMed ID: 7353539
    [Abstract] [Full Text] [Related]

  • 9. Decreased responsiveness of GH3 cells to the dopaminergic inhibition of prolactin.
    Faure N, Cronin MJ, Martial JA, Weiner RI.
    Endocrinology; 1980 Oct; 107(4):1022-6. PubMed ID: 6157521
    [Abstract] [Full Text] [Related]

  • 10. In vitro and in vivo antagonistic regulation by estradiol and progesterone of the rat pituitary domperidone binding sites: correlation with ovarian steroid regulation of the dopaminergic inhibition of prolactin secretion in vitro.
    Bression D, Brandi AM, Pagesy P, Le Dafniet M, Martinet M, Brailly S, Michard M, Peillon F.
    Endocrinology; 1985 May; 116(5):1905-11. PubMed ID: 3987624
    [Abstract] [Full Text] [Related]

  • 11. Autoparacrine action of vasoactive intestinal peptide on dopaminergic control of prolactin secretion.
    Balsa JA, Sánchez-Franco F, Lorenzo MJ, Pazos F, Lara JI, Cacicedo L.
    Endocrinology; 1996 Feb; 137(2):508-13. PubMed ID: 8593796
    [Abstract] [Full Text] [Related]

  • 12. Interactions of dopaminergic and peptidergic factors in the control of prolactin release.
    Mogg RJ, Samson WK.
    Endocrinology; 1990 Feb; 126(2):728-35. PubMed ID: 2298169
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Correlation of alpha- and beta-rotameric forms of 2-substituted octahydrobenzo[f]quinoline dopamine congeners with high and low affinity states of the anterior pituitary dopamine receptor and prolactin inhibition.
    Findell PR, Torkelson SM, Craig JC, Weiner RI.
    Mol Pharmacol; 1988 Jan; 33(1):78-83. PubMed ID: 3336350
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [3H]Apomorphine binding to a GTP-sensitive dopaminergic site in bovine anterior pituitary gland.
    Di Paolo T, Gagné B, Poyet P, Labrie F.
    Can J Biochem; 1982 Nov; 60(11):1043-9. PubMed ID: 7172091
    [Abstract] [Full Text] [Related]

  • 18. Resumption of prolactin secretion after dopaminergic inhibition: differential effects of dopamine and its agonists.
    Woolf PD.
    Am J Physiol; 1981 Jun; 240(6):E700-4. PubMed ID: 7246736
    [Abstract] [Full Text] [Related]

  • 19. Attenuation of anterior pituitary phosphoinositide phosphorylase activity by the D2 dopamine receptor.
    Jarvis WD, Judd AM, MacLeod RM.
    Endocrinology; 1988 Dec; 123(6):2793-9. PubMed ID: 2904359
    [Abstract] [Full Text] [Related]

  • 20. Dihydropyridine-sensitive calcium channel activity related to prolactin, growth hormone, and luteinizing hormone release from anterior pituitary cells in culture: interactions with somatostatin, dopamine, and estrogens.
    Drouva SV, Rerat E, Bihoreau C, Laplante E, Rasolonjanahary R, Clauser H, Kordon C.
    Endocrinology; 1988 Dec; 123(6):2762-73. PubMed ID: 2461851
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.